Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

China Biotech in Review: New Developments
Seeking Alpha
Tuesday, June 23, 2009 - 8:37am
tags:
China, Eli Lilly, Pfizer, China Aoxing, NeoStem
We're Positive on Acorda
Yahoo/Zacks.com
Tuesday, June 23, 2009 - 8:35am
tags:
Acorda Therapeutics, Fampridine-SR
Biogen enrolls patients in new MS trial
Bizjournals.com
Tuesday, June 23, 2009 - 8:34am
tags:
Biogen Idec, drug trials, MS, multiple sclerosis
Pharma Announces $80B Reduction: Who Wins?
Seeking Alpha
Tuesday, June 23, 2009 - 7:44am
tags:
GSK, JNJ, Mylan, Novartis, Schering Plough, Sanofi, Teva Pharmaceuticals, Watson Pharmaceuticals
Obama Health Plan Gets Booster Shot With Drugmaker Pledge
Bloomberg
Tuesday, June 23, 2009 - 7:42am
tags:
Obama, healthcare reform
Big Pharma’s Divide and Conquer Strategy
Seeking Alpha
Tuesday, June 23, 2009 - 7:41am
tags:
Big Pharma, healthcare reform
Santarus: FDA sets action date on heartburn drug
Marketwatch
Tuesday, June 23, 2009 - 7:39am
tags:
FDA, Santarus, heartburn, Zegerid
Merck Issues $4.25 Billion of Notes in Its Biggest Bond Sale
Bloomberg
Tuesday, June 23, 2009 - 7:38am
tags:
Merck, bonds
AARP Wins One With Pharma Pledge on Medicare Doughnut Hole
WSJ Online
Monday, June 22, 2009 - 6:45pm
tags:
AARP, Medicare, healthcare reform, drug costs
Dendreon: Cash Out or Keep Riding Up?
Motley Fool
Monday, June 22, 2009 - 6:44pm
tags:
Dendreon, Provenge
Medarex Jumps on Drug Data
Yahoo/Zacks.com
Monday, June 22, 2009 - 4:24pm
tags:
Medarex, drug trials, ipilimumab, prostate cancer, Bristol-Myers Squibb
NeurogesX wins $42M-plus in Astellas Pharma deal
Bizjournals.com
Monday, June 22, 2009 - 4:21pm
tags:
NeurogesX, Astellas, Qutenza
GlaxoSmithKline Fundamentals Sound
Yahoo/Zacks.com
Monday, June 22, 2009 - 4:20pm
tags:
GSK, pipelines
Merck collaborates on tropical disease treatments
Yahoo/AP
Monday, June 22, 2009 - 4:17pm
tags:
Merck, tropical diseases
Biogen reports 9th case of rare brain infection in Tysabri patients since 2006 reintroduction
Yahoo/AP
Monday, June 22, 2009 - 11:39am
tags:
Biogen Idec, Tysabri, PML, MS, multiple sclerosis
Sanofi set to announce restructuring plans -union
Reuters
Monday, June 22, 2009 - 11:22am
tags:
Sanofi, restructuring
Pfizer willing to pay more for Wyeth
Fierce Pharma
Monday, June 22, 2009 - 11:21am
tags:
Pfizer, buyouts, Wyeth
FDA to meet in August to review potential blockbuster osteoporosis drug from Amgen
Yahoo/AP
Monday, June 22, 2009 - 11:19am
tags:
FDA, Amgen, osteoporosis, denosumab
ImmunoGen says underwriters bought shares in public offering, pushing proceeds to $38 million
Yahoo/AP
Monday, June 22, 2009 - 11:19am
tags:
Immunogen
MannKind Closes Acquisition of Insulin Assets from Pfizer
Yahoo
Monday, June 22, 2009 - 10:38am
tags:
MannKind, insulin, diabetes, Pfizer, Afresa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.